9 Meters Biopharma Inc. [NASDAQ: NMTR] surged by $0.2 during the normal trading session on Tuesday and reaching a high of $2.09 during the day while it closed the day at $1.93. The company report on February 3, 2021 that 9 Meters Biopharma, Inc. highlighted at upcoming Truist Securities’ CEO Strategic Vision Conference Call Series.
9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced its Executive Management team will participate in the “CEO Strategic Vision” Conference Call Series hosted by hosted by Srikripa Devarakonda, PhD and Robyn Karnauskas, PhD of Truist Securities on Wednesday, February 10, 2021. Please see additional details below:
CEO Strategic Vision Conference Call Series Date: Wednesday, February 10, 2021Time: 11:00 am Eastern Time.
9 Meters Biopharma Inc. stock has also gained 32.19% of its value over the past 7 days. However, NMTR stock has inclined by 166.94% in the 3 months of the year. Over the past six months meanwhile, it has gained 272.59% and gained 124.68% year-on date.
The market cap for NMTR stock reached $397.72 million, with 141.63 million shares outstanding and 116.68 million shares in the current float. Compared to the average trading volume of 10.05M shares, NMTR reached a trading volume of 21331981 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about 9 Meters Biopharma Inc. [NMTR]:
The Average True Range (ATR) for 9 Meters Biopharma Inc. is set at 0.19 The Price to Book ratio for the last quarter was 64.33, with the Price to Cash per share for the same quarter was set at 0.06.
NMTR stock trade performance evaluation
9 Meters Biopharma Inc. [NMTR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 32.19. With this latest performance, NMTR shares gained by 37.86% in over the last four-week period, additionally plugging by 272.59% over the last 6 months – not to mention a rise of 155.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NMTR stock in for the last two-week period is set at 74.57, with the RSI for the last a single of trading hit 77.74, and the three-weeks RSI is set at 72.07 for 9 Meters Biopharma Inc. [NMTR]. The present Moving Average for the last 50 days of trading for this stock 1.1363, while it was recorded at 1.8020 for the last single week of trading.
9 Meters Biopharma Inc. [NMTR]: An insightful look at the core fundamentals
9 Meters Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Earnings per share (EPS) analysis for 9 Meters Biopharma Inc. [NMTR] stock
With the latest financial reports released by the company, 9 Meters Biopharma Inc. posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.12/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -33.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NMTR.
9 Meters Biopharma Inc. [NMTR]: Insider Ownership positions
There are presently around $64 million, or 21.30% of NMTR stock, in the hands of institutional investors. The top three institutional holders of NMTR stocks are: ORBIMED ADVISORS LLC with ownership of 25,716,755, which is approximately 0% of the company’s market cap and around 0.90% of the total institutional ownership; BLACKROCK INC., holding 3,035,045 shares of the stock with an approximate value of $5.86 million in NMTR stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $1.78 million in NMTR stock with ownership of nearly New of the company’s market capitalization.
32 institutional holders increased their position in 9 Meters Biopharma Inc. [NASDAQ:NMTR] by around 5,662,107 shares. Additionally, 5 investors decreased positions by around 281,344 shares, while 9 investors held positions by with 27,125,370 shares. The mentioned changes placed institutional holdings at 33,068,821 shares, according to the latest SEC report filing. NMTR stock had 17 new institutional investments in for a total of 1,939,059 shares, while 3 institutional investors sold positions of 268,612 shares during the same period.